Complaint
| Name | UCB 34714 |
| CAS | 357336-20-0 |
| MF | C11H20N2O2 |
| MW | 212.29 |
| EINECS | 801-184-2 |
| Appearance | white powder |
| Categories | API;Anticonvulsant;Pharmaceutical |
| Uses | UCB 34714 is an orally bioavailable levetiracetam derivative, with anticonvulsant activity. It can be used in the treatment of partial-onset seizures. |
| UCB 34714 is an orally bioavailable levetiracetam derivative, with anticonvulsant activity. It can be used in the treatment of partial-onset seizures. |
